Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 115

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 115
---
, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application to all prior periods presented
in the financial statements is required for public entities. The Company adopted ASU 2023-07 as of January 1, 2024, which resulted in
additional disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures.

Other recent accounting pronouncements
issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have
a material impact on the Company’s present or future consolidated financial statements.

2. ACCOUNTS RECEIVABLE

Accounts receivable were comprised of the
following:

SCHEDULE OF ACCOUNTS RECEIVABLE

|                         |     |   |           As 
           of 
 December 31, 
         2024 |     |   |            As 
            of 
 September 30, 
          2024 |
|:------------------------|:----|:--|-------------:|:----|:--|--------------:|
| Licensee- Related Party |     |   |      122,298 |     |   |        94,873 |
| Total                   |     | $ |      122,298 |     | $ |        94,873 |

During the quarter ended December 31, 2024 there
was no allowance for doubtful accounts.

3. PREPAID EXPENSES

Prepaid Expenses were comprised of the
following:

SCHEDULE OF PREPAID EXPENSES

|                  |     |   |             As of 
 December 31, 2024 |     |   |             As of 
 September 30,2024 |
|:-----------------|:----|:--|------------------:|:----|:--|------------------:|
| Prepaid Expenses |     | $ |            51,250 |     | $ |            42,762 |
| Prepaid Rent     |     |   |                 - |     |   |             5,000 |
| Total            |     | $ |            51,250 |     | $ |            47,762 |

Prepaid expenses consist of payments of certain expenses
by cash or issuance of shares for which services are pending to be received.

4. INVESTMENTS

The Company classifies its investment securities as
available-for-sale. Available-for-sale securities are recorded at fair value,